Standardbred Canada Identification Technician Stephen MacLeod will be back in Prince Edward Island on Monday, July 10 to microchip foals of 2023 and any horses in the region requiring identification.
Truist Securities boosted the price target for BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from $125 to $140. Truist Securities analyst Robyn Karnauskas maintained a Buy rating. BioMarin Pharmaceutical shares fell 3.6% to close at $88.93 on Thursday.
Standardbred Canada Identification Technician Stephen MacLeod will be back in Prince Edward Island on Monday, June 26 to microchip foals of 2023 and any horses in the region requiring identification.